Compare Amphastar Pharmaceuticals Inc (AMPH) vs Newegg Commerce Inc (NEGG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Newegg Commerce Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while Newegg Commerce Inc trades at $18.97 (market cap $380.46M). The key difference: Amphastar Pharmaceuticals Inc is far larger — about 2.3× Newegg Commerce Inc's market cap, and Amphastar Pharmaceuticals Inc is trading nearer its 52-week high, Newegg Commerce Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | NEGG | |
|---|---|---|
Market Cap | $863.95M | $380.46M |
Sector | Health | Consumer Cyclical |
52-Week High | $30.81 | $128.09 |
52-Week Low | $16.87 | $12.87 |
Enterprise Value | $1.26B | $379.26M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
NEGG (Newegg Commerce) trades at $16.9, down 5.48% today, with a bullish technical signal from moving averages but an overbought RSI. The company reported a net loss of $4.88M in 2025, though revenue grew to $1.44B, and it has beaten EPS estimates in recent quarters. Recent news highlights product launches and AI shopping enhancements, signaling innovation efforts.
The outlook is mixed: profitability remains weak with a net margin of 0.39%, but low P/S of 0.26 suggests undervaluation. Risks include persistent negative cash flow from operations and high competition. Analyst consensus is bullish with 100% buy ratings, but investors should monitor earnings sustainability and cost management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Newegg Commerce Inc
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products and provides certain third-party logistics services globally.
Read more on NEGG →
